{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:30:23Z","timestamp":1787851823144,"version":"build-2784847793"},"reference-count":53,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["20H03694"],"award-info":[{"award-number":["20H03694"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19K08744"],"award-info":[{"award-number":["19K08744"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["21K08314"],"award-info":[{"award-number":["21K08314"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19K22574"],"award-info":[{"award-number":["19K22574"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["18cm0106340h0001"],"award-info":[{"award-number":["18cm0106340h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["20cm0106502h0005"],"award-info":[{"award-number":["20cm0106502h0005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["21cm0106383"],"award-info":[{"award-number":["21cm0106383"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["19ck0106521h0001"],"award-info":[{"award-number":["19ck0106521h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["22ck0106723h0001"],"award-info":[{"award-number":["22ck0106723h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MEXT | JST | Fusion Oriented REsearch for disruptive Science and Technology","award":["21-211033868"],"award-info":[{"award-number":["21-211033868"]}]},{"name":"Chiba Prefecture Research Grant","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Japanese Foundation for Multidisciplinary Treatment of Cancer Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/501100008880","name":"Kanae Foundation for the Promotion of Medical Science","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100008880","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008673","name":"Yasuda Memorial Medical Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100008673","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013236","name":"MSD Life Science Foundation, Public Interest Incorporated Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100013236","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004088","name":"Kowa Life Science Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004088","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008801","name":"Senri Life Science Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100008801","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015642","name":"Japan Lung Cancer Society","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100015642","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004051","name":"Kato Memorial Bioscience Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004051","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008664","name":"Ono Medical Research Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100008664","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003844","name":"Inamori Foundation","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100003844","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Japan Respiratory Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Ube Industries Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,28]]},"abstract":"<jats:p>Some patients experience mixed response to immunotherapy, whose biological mechanisms and clinical impact have been obscure. We obtained two tumor samples from lymph node (LN) metastatic lesions in a same patient. Whole exome sequencing for the both tumors and single-cell sequencing for the both tumor-infiltrating lymphocytes (TIL) demonstrated a significant difference in tumor clonality and TILs\u2019 characteristics, especially exhausted T-cell clonotypes, although a close relationship between the tumor cell and T-cell clones were observed as a response of an overlapped exhausted T-cell clone to an overlapped neoantigen. To mimic the clinical setting, we generated a mouse model of several clones from a same tumor cell line. Similarly, differential tumor clones harbored distinct TILs, and one responded to programmed cell death protein 1 (PD-1) blockade but the other did not in this model. We further conducted cohort study (n = 503) treated with PD-1 blockade monotherapies to investigate the outcome of mixed response. Patients with mixed responses to PD-1 blockade had a poor prognosis in our cohort. Particularly, there were significant differences in both tumor and T-cell clones between the primary and LN lesions in a patient who experienced tumor response to anti\u2013PD-1 mAb followed by disease progression in only LN metastasis. Our results underscore that intertumoral heterogeneity alters characteristics of TILs even in the same patient, leading to mixed response to immunotherapy and significant difference in the outcome.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Several patients experience mixed responses to immunotherapies, but the biological mechanisms and clinical significance remain unclear. Our results from clinical and mouse studies underscore that intertumoral heterogeneity alters characteristics of TILs even in the same patient, leading to mixed response to immunotherapy and significant difference in the outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0050","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T09:54:26Z","timestamp":1657533266000},"page":"739-753","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration"],"prefix":"10.1158","volume":"2","author":[{"given":"Takao","family":"Morinaga","sequence":"first","affiliation":[{"name":"1Chiba Cancer Center, Research Institute, Chiba, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Inozume","sequence":"additional","affiliation":[{"name":"1Chiba Cancer Center, Research Institute, Chiba, Japan."},{"name":"2Department of Dermatology, Graduate School of Medicine, Chiba University, Chiba, Japan."},{"name":"3Department of Dermatology, University of Yamanashi, Yamanashi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4146-3629","authenticated-orcid":true,"given":"Masahito","family":"Kawazu","sequence":"additional","affiliation":[{"name":"1Chiba Cancer Center, Research Institute, Chiba, Japan."},{"name":"4Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2627-8524","authenticated-orcid":true,"given":"Youki","family":"Ueda","sequence":"additional","affiliation":[{"name":"5Department of Tumor Microenvironment, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sax","sequence":"additional","affiliation":[{"name":"6KOTAI Biotechnologies Inc, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0085-2057","authenticated-orcid":true,"given":"Kazuo","family":"Yamashita","sequence":"additional","affiliation":[{"name":"6KOTAI Biotechnologies Inc, Osaka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Kawashima","sequence":"additional","affiliation":[{"name":"1Chiba Cancer Center, Research Institute, Chiba, Japan."},{"name":"2Department of Dermatology, Graduate School of Medicine, Chiba University, Chiba, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Nagasaki","sequence":"additional","affiliation":[{"name":"1Chiba Cancer Center, Research Institute, Chiba, Japan."},{"name":"5Department of Tumor Microenvironment, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-7298","authenticated-orcid":true,"given":"Toshihide","family":"Ueno","sequence":"additional","affiliation":[{"name":"4Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Lin","sequence":"additional","affiliation":[{"name":"1Chiba Cancer Center, Research Institute, Chiba, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9171-4724","authenticated-orcid":true,"given":"Yuuki","family":"Ohara","sequence":"additional","affiliation":[{"name":"7Department of Pathology, National Cancer Center Hospital East, Kashiwa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0044-953X","authenticated-orcid":true,"given":"Takeshi","family":"Kuwata","sequence":"additional","affiliation":[{"name":"8Department of Genetic Medicine and Services, National Cancer Center Hospital East, Kashiwa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7781-4609","authenticated-orcid":true,"given":"Hiroki","family":"Yukami","sequence":"additional","affiliation":[{"name":"9Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-3748","authenticated-orcid":true,"given":"Akihito","family":"Kawazoe","sequence":"additional","affiliation":[{"name":"9Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-3630","authenticated-orcid":true,"given":"Kohei","family":"Shitara","sequence":"additional","affiliation":[{"name":"9Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Honobe-Tabuchi","sequence":"additional","affiliation":[{"name":"3Department of Dermatology, University of Yamanashi, Yamanashi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Ohnuma","sequence":"additional","affiliation":[{"name":"3Department of Dermatology, University of Yamanashi, Yamanashi, Japan."},{"name":"10Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-2322","authenticated-orcid":true,"given":"Tatsuyoshi","family":"Kawamura","sequence":"additional","affiliation":[{"name":"3Department of Dermatology, University of Yamanashi, Yamanashi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Umeda","sequence":"additional","affiliation":[{"name":"11Department of Skin Oncology\/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kawahara","sequence":"additional","affiliation":[{"name":"11Department of Skin Oncology\/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"11Department of Skin Oncology\/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3757-7375","authenticated-orcid":true,"given":"Yukiko","family":"Kiniwa","sequence":"additional","affiliation":[{"name":"12Department of Dermatology, Shinshu University School of Medicine, Nagano, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Morita","sequence":"additional","affiliation":[{"name":"13Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2966-106X","authenticated-orcid":true,"given":"Eiki","family":"Ichihara","sequence":"additional","affiliation":[{"name":"13Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-9379","authenticated-orcid":true,"given":"Katsuyuki","family":"Kiura","sequence":"additional","affiliation":[{"name":"13Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Enokida","sequence":"additional","affiliation":[{"name":"14Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9035-3106","authenticated-orcid":true,"given":"Makoto","family":"Tahara","sequence":"additional","affiliation":[{"name":"14Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2904-6611","authenticated-orcid":true,"given":"Yoshinori","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"15Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4645-0181","authenticated-orcid":true,"given":"Hiroyuki","family":"Mano","sequence":"additional","affiliation":[{"name":"4Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"16Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6563-9807","authenticated-orcid":true,"given":"Hiroyoshi","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"17Division of Cancer Immunology, Research Institute\/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo\/Kashiwa, Japan."},{"name":"18Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9910-0164","authenticated-orcid":true,"given":"Yosuke","family":"Togashi","sequence":"additional","affiliation":[{"name":"1Chiba Cancer Center, Research Institute, Chiba, Japan."},{"name":"5Department of Tumor Microenvironment, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama, Japan."},{"name":"17Division of Cancer Immunology, Research Institute\/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo\/Kashiwa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci Transl Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion\u2019","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","article-title":"Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538\u201312, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Kang","year":"2017","journal-title":"Lancet"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","article-title":"Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers","volume":"25","author":"Scheper","year":"2019","journal-title":"Nat Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N Engl J Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri.2017.76","article-title":"Single-cell RNA sequencing to explore immune cell heterogeneity","volume":"18","author":"Papalexi","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","article-title":"Integrative single-cell analysis","volume":"20","author":"Stuart","year":"2019","journal-title":"Nat Rev Genet"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccell.2020.03.008","article-title":"Advancing Cancer Research and Medicine with Single-Cell Genomics","volume":"37","author":"Lim","year":"2020","journal-title":"Cancer Cell"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"110331","DOI":"10.1016\/j.celrep.2022.110331","article-title":"PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes","volume":"38","author":"Nagasaki","year":"2022","journal-title":"Cell Rep"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"23662","DOI":"10.1073\/pnas.1906026116","article-title":"Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens","volume":"116","author":"Linette","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/2159-8290.CD-16-0828","article-title":"Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer","volume":"7","author":"Anagnostou","year":"2017","journal-title":"Cancer Discov"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1245\/s10434-020-08657-6","article-title":"Mixed Response to Immunotherapy in Patients with Metastatic Melanoma","volume":"27","author":"Rauwerdink","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nmeth.2883","article-title":"PyClone: statistical inference of clonal population structure in cancer","volume":"11","author":"Roth","year":"2014","journal-title":"Nat Methods"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13059-015-0647-8","article-title":"Fast and scalable inference of multi-sample cancer lineages","volume":"16","author":"Popic","year":"2015","journal-title":"Genome Biol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nmeth.4303","article-title":"E-scape: interactive visualization of single-cell phylogenetics and cancer evolution","volume":"14","author":"Smith","year":"2017","journal-title":"Nat Methods"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-008-0341-z","article-title":"NetMHCpan, a method for MHC class I binding prediction beyond humans","volume":"61","author":"Hoof","year":"2009","journal-title":"Immunogenetics"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data","volume":"199","author":"Jurtz","year":"2017","journal-title":"J Immunol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"Hafemeister","year":"2019","journal-title":"Genome Biol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ng.3822","article-title":"Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire","volume":"49","author":"Emerson","year":"2017","journal-title":"Nat Genet"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat Methods"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","article-title":"The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat Immunol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8\u207a tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"Gros","year":"2014","journal-title":"J Clin Invest"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","article-title":"Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma","volume":"596","author":"Oliveira","year":"2021","journal-title":"Nature"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2020.01.014","article-title":"Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP","volume":"52","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1126\/science.1227049","article-title":"Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory","volume":"338","author":"Pace","year":"2012","journal-title":"Science"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1111\/cas.14605","article-title":"Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer","volume":"111","author":"Kagawa","year":"2020","journal-title":"Cancer Sci"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1245\/s10434-019-07487-5","article-title":"Impact of effective systemic therapy on metastasectomy in stage IV melanoma: a matched-pair analysis","volume":"26","author":"Nelson","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"2023031315302223700_","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10120-020-01058-4","article-title":"Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer","volume":"23","author":"Sasaki","year":"2020","journal-title":"Gastric Cancer"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0050\/3179502\/crc-22-0050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/2\/7\/739\/3282433\/crc-22-0050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/2\/7\/739\/3282433\/crc-22-0050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T07:26:32Z","timestamp":1700810792000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/2\/7\/739\/707275\/Mixed-Response-to-Cancer-Immunotherapy-is-Driven"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,28]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0050","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.22545383.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545377.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6550916.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545359","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545374.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6550916","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545341","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545353","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545371.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545341.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545365","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545377","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545386.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545338.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545371","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545383","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545353.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545338","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545344.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545362","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545374","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545386","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545359.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545344","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545356","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545368","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545368.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545365.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545350.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545362.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545356.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22545350","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]}}}